Agilent Technologies Inc. has launched the Agilent S540MD Slide Scanner System in the United States. The launch follows FDA clearance for the whole slide imaging (WSI) digital scanner. The Agilent S540MD Slide Scanner System expands Agilent’s digital pathology portfolio. It also addresses the growing need for high-throughput solutions across clinical laboratories.
Pathology labs are under increasing pressure for diagnostic efficiency. They also have to deal with increasing sample volumes and changing workflow requirements. “That’s why a lot of labs are still accelerating their digital transformation programs.” Digital pathology opens new avenues for AI-driven diagnostic workflows. But for this transition, laboratories need strong scanning technologies. They also need solutions that can be easily incorporated into existing pathology workflows.
The Agilent S540MD provides the speed, capacity and scalability to meet these needs. The system can hold 540 slides. It is also continuously loaded and uses standard racking. The scanner also includes automatic scan modes and advanced tissue detection features. Such features are helpful in labs to digitize glass slides. They are also suitable for high-volume and large scale digital pathology workflows.
The scanner represents the Agilent-branded version of the Hamamatsu NanoZoomer S540MD Slide scanner system. As a result, Agilent strengthens its digital pathology offering while building on established scanning technology.
“The introduction of the Agilent S540MD Slide Scanner System in the United States represents an important milestone in our commitment to helping customers advance their digital pathology capabilities, driving digital adoption and enhancing efficiency throughout their staining workflows.” said Majken Nielsen, vice president and general manager of Agilent’s Clinical Diagnostics Division. “By combining advanced scanning technology with Agilent’s pathology expertise, we are providing laboratories with an integrated experience that supports their evolving diagnostic and workflow needs.”
Advancing Digital Pathology Workflows
Agilent said the U.S. launch is important for laboratories employing digital pathology technologies.
The announcement follows the launch of the Agilent S540MD Slide Scanner System in selected European markets. In those markets Agilent launched the system in January 2026. This latest launch underscores Agilent’s continued commitment to digital pathology. It also supports laboratories in their efforts to streamline the diagnostic process. It also enables labs to improve operational efficiency throughout their workflows. It can also help get them ready for the wider use of AI-powered pathology solutions.
Availability Across the U.S. and Europe
The Agilent S540MD Slide Scanner System is now available throughout the United States. Agilent also offers the system across several European markets. These markets include Germany, the United Kingdom, France, Italy, and Spain. The list also includes Switzerland, Austria, Belgium, and the Netherlands. Additionally, availability extends to Luxembourg, Denmark, Sweden, Norway, and Finland. This broader availability gives more pathology laboratories access to Agilent’s digital scanning capabilities.
The launch further extends Agilent’s footprint in the digital pathology market. The company also reiterated its commitment to help labs as diagnostic needs change. This is a system designed for high-volume labs with high slide capacity and continuous loading. Automated scanning and tissue detection allows for efficient digitization of slides.
As digital pathology adoption continues to grow, laboratories increasingly seek scalable technology. They also require systems that can support future AI-enabled workflows. The Agilent S540MD therefore adds another solution to Agilent’s growing digital pathology portfolio. The U.S. launch marks another step in the company’s efforts to help laboratories modernize pathology operations.
Explore Health Tech Insiders for the latest medical innovations and reliable strategic insights driving the future of technology-driven healthcare transformation.
News Source: Businesswire.com
